• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Bakery franchise chain Crumbl explores $2 billion sale, sources say

by January 13, 2025
written by January 13, 2025

By Abigail Summerville

NEW YORK (Reuters) – The owners of Crumbl are exploring a sale that could value the popular cookie chain at nearly $2 billion, including debt, according to people familiar with the matter.

The Lindon, Utah-based bakery franchise chain is working with investment bank North Point on a sale process that could attract interest from private equity firms, the sources said, requesting anonymity as the matter is confidential.

The owners of the cookie chain are hoping to command a valuation for the business equivalent to more than 10 times its annual earnings before interest, taxes, depreciation, and amortization of nearly $150 million, the sources said.

Crumbl and North Point did not immediately respond to requests for comment.

Launched in 2017 by cousins Jason McGowan and Sawyer Hemsley, Crumbl in recent years has amassed a sizable social media following across platforms such as TikTok, Instagram, and YouTube.

The company, which sells its cookies in a distinctive pink box with its logo, opened its first location in 2017 in Logan, Utah, when Hemsley was finishing his degree at Utah State University. Crumbl is now present in 1,071 locations across North America, according to its website.

The dessert chain’s move to explore a sale comes as large investment firms are actively acquiring franchise operators, which typically generate steady royalty fees and are less expensive to operate.

Last year, Verlinvest and Mistral Equity Partners acquired Insomnia Cookies from Krispy Kreme (NASDAQ:DNUT) in a deal worth $350 million.

In December, Reuters reported private equity firm Bain Capital is in talks to acquire restaurant franchise operator Sizzling Platter.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Castle Biosciences stock tumbles following guidance concerns
next post
Blueprint Medicines shares surge on growth strategy and upbeat trial data

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Netflix says its ad tier now has 94 million monthly active users

      May 15, 2025
    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion

      May 15, 2025
    • YouTube will stream NFL Week 1 game in Brazil for free

      May 15, 2025
    • 5 new Uber features you should know — including a way to avoid surge pricing

      May 15, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (463)
    • Stock (6,426)

    Latest News

    • Netflix says its ad tier now has 94 million monthly active users
    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion

    Popular News

    • US rate futures price in more Fed easing in December and 2025
    • Morning Bid: Monster payrolls see 10-year Treasury yields top 4%

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy